Orpea SA Logo

Orpea SA

ORP.PA

(1.8)
Stock Price

12,31 EUR

-34.61% ROA

40.09% ROE

-0x PER

Market Cap.

2.037.351.654,00 EUR

-891.31% DER

0% Yield

-7.13% NPM

Orpea SA Stock Analysis

Orpea SA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Orpea SA Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-0.02x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (-891%), which means it has a small amount of debt compared to the ownership it holds

3 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

4 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-347.64%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-34.61%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Orpea SA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Orpea SA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Orpea SA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Orpea SA Revenue
Year Revenue Growth
2004 237.088.000
2005 309.637.000 23.43%
2006 414.944.000 25.38%
2007 544.602.000 23.81%
2008 702.321.000 22.46%
2009 843.321.000 16.72%
2010 964.234.000 12.54%
2011 1.234.130.000 21.87%
2012 1.429.263.000 13.65%
2013 1.607.922.000 11.11%
2014 1.948.580.000 17.48%
2015 2.391.604.000 18.52%
2016 2.841.225.000 15.82%
2017 3.138.234.000 9.46%
2018 3.419.764.000 8.23%
2019 3.740.215.000 8.57%
2020 3.922.392.000 4.64%
2021 4.298.574.000 8.75%
2022 4.589.108.000 6.33%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Orpea SA Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Orpea SA General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Orpea SA EBITDA
Year EBITDA Growth
2004 38.528.000
2005 83.674.000 53.95%
2006 77.203.000 -8.38%
2007 125.505.000 38.49%
2008 124.097.000 -1.13%
2009 151.474.000 18.07%
2010 185.953.000 18.54%
2011 236.039.000 21.22%
2012 252.040.000 6.35%
2013 294.983.000 14.56%
2014 353.823.000 16.63%
2015 395.498.000 10.54%
2016 458.722.000 13.78%
2017 514.554.000 10.85%
2018 601.454.000 14.45%
2019 948.928.000 36.62%
2020 930.383.000 -1.99%
2021 1.010.021.000 7.88%
2022 537.462.000 -87.92%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Orpea SA Gross Profit
Year Gross Profit Growth
2004 171.212.000
2005 230.088.000 25.59%
2006 310.217.000 25.83%
2007 400.595.000 22.56%
2008 516.925.000 22.5%
2009 623.664.000 17.11%
2010 712.238.000 12.44%
2011 900.239.000 20.88%
2012 1.041.357.000 13.55%
2013 1.176.743.000 11.51%
2014 1.399.670.000 15.93%
2015 1.693.053.000 17.33%
2016 2.023.856.000 16.35%
2017 2.276.769.000 11.11%
2018 2.504.164.000 9.08%
2019 3.021.551.000 17.12%
2020 3.173.555.000 4.79%
2021 3.453.338.000 8.1%
2022 835.742.000 -313.21%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Orpea SA Net Profit
Year Net Profit Growth
2004 19.483.000
2005 38.111.000 48.88%
2006 32.448.000 -17.45%
2007 41.237.000 21.31%
2008 48.378.000 14.76%
2009 61.138.000 20.87%
2010 66.347.000 7.85%
2011 80.316.000 17.39%
2012 97.028.000 17.22%
2013 113.911.000 14.82%
2014 120.777.000 5.68%
2015 126.634.000 4.63%
2016 256.440.000 50.62%
2017 89.789.000 -185.6%
2018 220.391.000 59.26%
2019 233.990.000 5.81%
2020 160.046.000 -46.2%
2021 65.185.000 -145.53%
2022 -537.642.000 112.12%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Orpea SA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 1
2005 1 0%
2006 1 0%
2007 1 100%
2008 1 0%
2009 1 0%
2010 2 0%
2011 2 0%
2012 2 0%
2013 2 50%
2014 2 0%
2015 2 0%
2016 4 50%
2017 1 -300%
2018 3 66.67%
2019 4 0%
2020 2 -50%
2021 1 -100%
2022 -8 112.5%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Orpea SA Free Cashflow
Year Free Cashflow Growth
2004 -58.500.000
2005 -81.297.000 28.04%
2006 -150.027.000 45.81%
2007 -56.206.000 -166.92%
2008 -228.282.000 75.38%
2009 -158.558.000 -43.97%
2010 -192.579.000 17.67%
2011 -152.676.000 -26.14%
2012 83.996.000 281.77%
2013 91.664.000 8.37%
2014 -126.202.000 172.63%
2015 130.348.000 196.82%
2016 346.709.000 62.4%
2017 397.904.000 12.87%
2018 415.112.000 4.15%
2019 806.458.000 48.53%
2020 777.730.000 -3.69%
2021 753.751.000 -3.18%
2022 151.801.000 -396.54%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Orpea SA Operating Cashflow
Year Operating Cashflow Growth
2004 33.767.000
2005 63.149.000 46.53%
2006 69.683.000 9.38%
2007 87.962.000 20.78%
2008 100.183.000 12.2%
2009 127.004.000 21.12%
2010 135.611.000 6.35%
2011 202.250.000 32.95%
2012 208.140.000 2.83%
2013 247.279.000 15.83%
2014 290.143.000 14.77%
2015 313.939.000 7.58%
2016 346.709.000 9.45%
2017 397.904.000 12.87%
2018 415.112.000 4.15%
2019 806.458.000 48.53%
2020 777.730.000 -3.69%
2021 753.751.000 -3.18%
2022 175.832.500 -328.68%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Orpea SA Capital Expenditure
Year Capital Expenditure Growth
2004 92.267.000
2005 144.446.000 36.12%
2006 219.710.000 34.26%
2007 144.168.000 -52.4%
2008 328.465.000 56.11%
2009 285.562.000 -15.02%
2010 328.190.000 12.99%
2011 354.926.000 7.53%
2012 124.144.000 -185.9%
2013 155.615.000 20.22%
2014 416.345.000 62.62%
2015 183.591.000 -126.78%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 24.031.500 100%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Orpea SA Equity
Year Equity Growth
2004 197.866.000
2005 232.845.000 15.02%
2006 260.872.000 10.74%
2007 500.556.000 47.88%
2008 540.678.000 7.42%
2009 641.628.000 15.73%
2010 865.353.000 25.85%
2011 1.151.650.000 24.86%
2012 1.214.279.000 5.16%
2013 1.412.374.000 14.03%
2014 1.497.968.000 5.71%
2015 1.809.520.000 17.22%
2016 2.075.828.000 12.83%
2017 2.715.166.000 23.55%
2018 2.970.674.000 8.6%
2019 3.011.123.000 1.34%
2020 3.489.959.000 13.72%
2021 3.811.228.000 8.43%
2022 -1.502.236.000 353.7%
2023 -1.849.740.000 18.79%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Orpea SA Assets
Year Assets Growth
2004 689.732.000
2005 853.958.000 19.23%
2006 1.167.140.000 26.83%
2007 2.039.772.000 42.78%
2008 2.571.872.000 20.69%
2009 3.061.189.000 15.98%
2010 3.880.050.000 21.1%
2011 4.481.784.000 13.43%
2012 4.955.009.000 9.55%
2013 5.451.590.000 9.11%
2014 6.286.187.000 13.28%
2015 7.371.324.000 14.72%
2016 8.325.564.000 11.46%
2017 9.695.482.000 14.13%
2018 11.144.573.000 13%
2019 14.539.021.000 23.35%
2020 16.966.502.000 14.31%
2021 18.984.327.000 10.63%
2022 14.494.434.000 -30.98%
2023 14.684.680.000 1.3%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Orpea SA Liabilities
Year Liabilities Growth
2004 490.319.000
2005 619.145.000 20.81%
2006 906.209.000 31.68%
2007 1.539.158.000 41.12%
2008 2.030.910.000 24.21%
2009 2.419.304.000 16.05%
2010 2.985.447.000 18.96%
2011 3.327.237.000 10.27%
2012 3.739.243.000 11.02%
2013 4.038.237.000 7.4%
2014 4.787.840.000 15.66%
2015 5.561.614.000 13.91%
2016 6.249.537.000 11.01%
2017 6.980.103.000 10.47%
2018 8.173.899.000 14.6%
2019 11.527.898.000 29.09%
2020 13.476.543.000 14.46%
2021 15.173.099.000 11.18%
2022 15.996.670.000 5.15%
2023 16.534.420.000 3.25%

Orpea SA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
72.45
Net Income per Share
-61.82
Price to Earning Ratio
-0x
Price To Sales Ratio
0.44x
POCF Ratio
0
PFCF Ratio
4.97
Price to Book Ratio
-0
EV to Sales
3.11
EV Over EBITDA
103.22
EV to Operating CashFlow
35.55
EV to FreeCashFlow
35.55
Earnings Yield
-4177.27
FreeCashFlow Yield
0.2
Market Cap
2,04 Bil.
Enterprise Value
14,56 Bil.
Graham Number
179.8
Graham NetNet
-234.22

Income Statement Metrics

Net Income per Share
-61.82
Income Quality
-0.1
ROE
-3.48
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
1.13
EBT Per Ebit
-0.12
Ebit per Revenue
0.51
Effective Tax Rate
-0.12

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.51
Operating Profit Margin
0.51
Pretax Profit Margin
-0.06
Net Profit Margin
-0.07

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
6.34
Free CashFlow per Share
6.34
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.04
Return on Tangible Assets
-0.35
Days Sales Outstanding
0
Days Payables Outstanding
127.06
Days of Inventory on Hand
6.26
Receivables Turnover
0
Payables Turnover
2.87
Inventory Turnover
58.34
Capex per Share
0

Balance Sheet

Cash per Share
13,26
Book Value per Share
-23,24
Tangible Book Value per Share
-68.98
Shareholders Equity per Share
-23.24
Interest Debt per Share
212.32
Debt to Equity
-8.91
Debt to Assets
0.92
Net Debt to EBITDA
88.78
Current Ratio
0.23
Tangible Asset Value
-4,46 Bil.
Net Current Asset Value
-13,73 Bil.
Invested Capital
-8.91
Working Capital
-7,75 Bil.
Intangibles to Total Assets
0.2
Average Receivables
0,00 Bil.
Average Payables
0,33 Bil.
Average Inventory
15917500
Debt to Market Cap
6.57

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Orpea SA Dividends
Year Dividends Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 100%
2018 1 0%
2019 1 0%
2021 1 0%

Orpea SA Profile

About Orpea SA

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

CEO
Mr. Laurent Guillot
Employee
76.000
Address
12, rue Jean-JaurEs
Puteaux, 92813

Orpea SA Executives & BODs

Orpea SA Executives & BODs
# Name Age
1 Benoit Lesieur
Investor Relations Director
70
2 Dr. Linda Benattar M.D.
President of the Group Medical Committee
70
3 Ms. Laure Freres
EVice President of Wellbeing and In Charge of Medical, Quality & CSR
70
4 Mr. Emmanuel Masson
Executive Vice President of Expansion & Network Development
70
5 Mr. Laurent Lemaire
Group Executive Vice President of Finance, Procurement & Information Systems
70
6 Mr. Bertrand Desriaux
Executive Vice President of Human Resources
70
7 Mr. Laurent Guillot
Chief Executive Officer & Director
70
8 Mr. Sebastien Mesnard
Director of Group Financing & Accounting
70
9 Yamina Emmungil
Head of Legal Affairs
70
10 Mr. Leonard Addesso
Executive Vice President of Construction
70

Orpea SA Competitors

Korian Logo
Korian

KORI.PA

(2.2)
Atos SE Logo
Atos SE

ATO.PA

(1.0)
Rubis Logo
Rubis

RUI.PA

(2.8)
L'Air Liquide S.A. Logo
L'Air Liquide S.A.

AI.PA

(3.0)
Eurofins Scientific SE Logo
Eurofins Scientific SE

ERF.PA

(2.0)